Pilot study of directly observed therapy in highly nonadherent HIV-infected patients in an urban community-based institution [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 5, 2003, Pages 651-653

  Khanlou, Homayoun ^a   Kandula, Vijayabhaskar R ^a   Yeh, Vivian ^a   Stein, Tomiko G ^a   Sanchez, Susan ^a   Ricuarte, Juan Carlos ^a   Bhatti, Laveeza ^a   Farthing, Charles F ^a  

^a AIDS HEALTHCARE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; NEVIRAPINE; RITONAVIR; SAQUINAVIR;

CELL COUNT; CLINICAL TRIAL; DIRECTLY OBSERVED THERAPY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CALIFORNIA; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; PILOT PROJECTS; URBAN POPULATION;

EID: 0042126688     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200308150-00017     Document Type: Letter

References (12)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;129:504-505.
2. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81-87.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
4. th Conference on Retrovirus and Opportunistic infections; 2001; Chicago; IL.
5. ST International Conference on Antimicrobial Agents and Chemotherapy; 2000; San Diego, CA.
6. Clarke S, Keenan E, Ryan M, et al. Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Reader. 2002;12:305-316.
7. Lucas G, Weidle P, Moore R. Directly observed therapy improves rates of viral suppression compared to standard care and an intensive adherence regimen. Abstract presented at: Elements of Success Conference; 2002; Dallas, TX.
8. Babudiere S, Aceti A, D'Offizi GP, et al. Directly observed therapy to treat HIV infection in prisoners. JAMA. 2000;284:179-180.
9. Lanzafame M, Trevenzoli M, Cattelan AM, et al. Directly observed therapy in HIV therapy: a realistic perspective? J Acquir Immune Defic Syndr. 2000;25:200-201.
10. Mitty JA, McKenzie M, Stenzel M, et al. Modified directly observed therapy for treatment of human immunodeficiency virus. JAMA. 1999;282:1334-1335.
11. Adair M, Myers J, Denouden P, et al. Sustained antiretroviral adherence following a short-term directly observed therapy. Abstract presented at: The Elements of Success Conference 2002; Dallas, TX.
12. Kennedy BL, O'Malley, Khanlou H, et al. Heterogeneity of patient's adherence profile to antiretroviral therapy in HIV-infected patients. J Acquir Immune Defic Syndr. 2001;28:307-308.